A Rare Complication: Development of an Aspergilloma after Endobronchial Coil Placement in a COPD Patient

Plante, Alexandre; Guinde, Julien; Boudreau, C. A.; Maltais, François; Martel, Simon; Delage, Antoine; Fortin, Marc

doi:10.1159/000503363

Cited by 2 publications

(6 citation statements)

References 11 publications

(13 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At the time of the coil insertion the patient was colonized with Aspergillus spp. without evidence of active infection 20. In our case report, multiple aspergillomas developed 4 years after the coil insertions.…”

Section: Discussionmentioning

confidence: 49%

Late Onset Pulmonary Complications After Bronchoscopic Coil Lung Volume Reduction

Ehab

Graeter²,

Hagemann

et al. 2021

Journal of Bronchology &Amp; Interventional Pulmonology

View full text Add to dashboard Cite

Other advantages of Arista AH include simplicity of use, low cost, and widespread availability in hospital operating rooms.Recent publications have described the use of Arista AH powder for endoscopic sinus surgery, 7 neurosurgery, 8 prostatectomy with lymphadenectomy 9 all resulting in reduced bleeding. To our knowledge, this is the first case of the endobronchial use of Arista AH. In this case, it was a life-saving measure after exhaustion of the other more traditional therapies. The use of this hemostatic proved to be useful and merits further consideration in the treatment of refractory life-threatening hemoptysis.

show abstract

Section: Discussionmentioning

confidence: 49%

Late Onset Pulmonary Complications After Bronchoscopic Coil Lung Volume Reduction

Ehab

Graeter²,

Hagemann

et al. 2021

Journal of Bronchology &Amp; Interventional Pulmonology

View full text Add to dashboard Cite

show abstract

“…Aspergillus was not detected in ongoing cultures, clinical findings of the patient were stabilized and the follow-up continued. These two case reports highlight this rare complication, especially in the long term [29,30].…”

Section: Aspergillus Cavitation (Coil-related Aspergilloma)mentioning

confidence: 73%

“…However, Acinetobacter, Alcaligenes, Pseudomonas, Comamonas, Stenotrophomonas, and Aspergillus families can develop nickel resistance through plasmids and may contribute to CAO or pneumonia [50]. An example of this are the cases of Aspergillus-associated cavitation [29,30]. It is thus clear that this issue requires further research.…”

Section: Discussionmentioning

confidence: 99%

“…Two case reports on this complication have been recently published [29,30]. First case concerned the patient who underwent bilateral endobronchial coil treatment during the RENEW trial and developed a 27-mm cavity in the left upper lobe [29].…”

Section: Aspergillus Cavitation (Coil-related Aspergilloma)mentioning

confidence: 99%

“…The patient was treated with voriconazole for 3 months and died due to decompensated respiratory failure. In the second case, the patient underwent endobronchial coil treatment for both upper lobes 3 years earlier [30]. Fungal cultures obtained during the procedure were positive for Aspergillus species, evaluated as colonization.…”

Section: Aspergillus Cavitation (Coil-related Aspergilloma)mentioning

confidence: 99%

See 2 more Smart Citations

Bronchoscopic Lung Volume Reduction Using Coil Therapy: Complications and Management

Gülşen

2020

Advances in Respiratory Medicine

View full text Add to dashboard Cite

Nonsurgical approaches involving bronchoscopic lung volume reduction (BLVR) have been developed in the last decade. One of these, the BLVR coil procedure, is a treatment option for patients with homogeneous and heterogeneous end-stage emphysema and a forced expiratory volume in 1 second (FEV1) of 15–45%. This treatment decreases hyperinflation and improves lung function, the quality of life, and exercise capacity. It is very important to prepare patients for treatment, premedications, anesthesia applications, intubation, post-procedure follow-up and treatments. Further, it has been observed that various complications can develop during and after the procedure. Generally, the observed and reported complications are chronic obstructive pulmonary disease (COPD) exacerbation, chest pain, mild bleeding, pneumonia, pneumothorax, and respiratory failure. Rarely, aspergillus cavitation (coil-related aspergilloma), bronchopleural fistula and penetration into the pleural space, bronchiectasis, coil-associated inflammatory response and opacities, and hiccups are observed. Common complications are usually mild or moderate, while the rare ones can be life-threatening (except hiccup), so early diagnosis and treatment are necessary. However, patients treated with BLVR have lower mortality rates than untreated patients with similar morbidity. Based on the findings of this review, we can estimate that premedication one day before and just before the procedure may reduce potential complications. Some medical centers apply and recommend 30-day macrolide treatment after the procedure. New generation supraglottic devices may be preferred to avoid complications due to endotracheal intubation. Moreover, further research is needed to identify risk factors, prevent potential complications, and a common consensus is required for routine preventive treatment.

show abstract

A Rare Complication: Development of an Aspergilloma after Endobronchial Coil Placement in a COPD Patient

Cited by 2 publications

References 11 publications

Late Onset Pulmonary Complications After Bronchoscopic Coil Lung Volume Reduction

Late Onset Pulmonary Complications After Bronchoscopic Coil Lung Volume Reduction

Bronchoscopic Lung Volume Reduction Using Coil Therapy: Complications and Management

Contact Info

Product

Resources

About